November 7th, 2026KRAS::ETNK1 Fusion Identified in MDS/MPN Overlap With EosinophiliaA case report describes the first KRAS::ETNK1 fusion in MDS/MPN with eosinophilia; the fusion disappeared when disease relapsed as AML after transplant.Read more
November 6th, 2026BTK Inhibitor Discontinuation Outpaces CLL Trials in Community Care Most patients with CLL/SLL who discontinued a first-line BTK inhibitor did not start second-line therapy, and older age was linked to worse outcomes. Read more
November 6th, 2026T-Cell Expansion Tracks With Response to Venetoclax-HMA Therapy in AMLA study of 132 patients with AML given venetoclax-based therapy, 10 profiled by single-cell sequencing, linked immune features to treatment response.Read more
November 6th, 2026Real-World Resmetirom Results Rival Trials: Parvez Mantry, MDParvez Mantry, MD, shares real-world resmetirom data from AASLD 2026, including GLP-1 combination use and biopsy-sparing monitoring.Read more
November 6th, 2026Measles Antibody VMS063 and Immune Amnesia: Michael Mina, MD, PhDMichael Mina, MD, PhD, of Invivyd, on measles antibody VMS063, immune amnesia, and what RSV antibody uptake signals for payers.Read more
November 5th, 2026Rituximab Maintenance After Frontline BR Linked to Longer MCL SurvivalPooled data on 2698 patients tie rituximab maintenance after bendamustine-rituximab to better PFS and OS in mantle cell lymphoma.Read more
November 5th, 2026Unmet Goals Should Prompt COPD Support Review: Gerard Criner, MDGerald Criner, MD, outlines which patients with advanced COPD may need oxygen, home NIV, or high-flow therapy and when to discuss goals of care.Read more